| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |